CogniFit teams with Eurofins Optimed on digital cognitive testing in early trials

CogniFit has partnered with Eurofins Optimed to support an ongoing early clinical research study with its digital cognitive assessment platform. The collaboration is aimed at bringing more standardized, scalable cognitive endpoints into First-in-Human and Phase I/II research.

Why it matters: - The collaboration adds digital cognitive assessment tools to early-stage clinical research, where sponsors need sensitive endpoints and efficient study workflows. - CogniFit's platform is designed to support participant selection, track cognitive change over time and generate standardized data across development programs. - Eurofins Optimed's use of digital endpoints reflects broader demand for remotely deployable tools in clinical trials.

What happened: - CogniFit announced a new collaboration with Eurofins Optimed to support an ongoing clinical research study. - Eurofins Optimed is using CogniFit's digital cognitive assessment platform in the study. - The announcement was made Aug. 19, 2026.

The details: - Eurofins Optimed is an early-phase contract research organization within the Eurofins network of companies. - The organization has more than 35 years of experience in early clinical development. - Eurofins Optimed focuses on First-in-Human, Phase I and early Phase II studies. - Its services include protocol design, regulatory strategy, clinical operations, bioanalysis, biometrics and study reporting. - The company supports work through a Clinical Trials Unit in France and an international network of investigators. - CogniFit's platform provides sensitive, rapid and standardized measurements of cognitive performance. - The platform supports reliable cognitive endpoints, longitudinal monitoring and scalable digital assessments. - CogniFit's Clinical Trials platform also includes electronic Clinical Outcome Assessments, custom cognitive assessment protocols, scientific consulting, longitudinal monitoring and remote and decentralized cognitive assessment capabilities. - CogniFit said its technology is used by more than 1,000 clinical studies and research institutions worldwide. - CogniFit's website for clinical trials is Clinical Trials platform. - Eurofins Optimed's website is Eurofins Optimed.

Between the lines: - The partnership signals continued movement in clinical research toward digital measures that can be deployed across sites and studies with less friction. - CogniFit is positioning its clinical research business around validated cognitive endpoints, not just consumer brain health products. - The study details remain confidential, so the immediate clinical use case is not public.

What's next: - The ongoing study will continue with CogniFit's assessment platform embedded in Eurofins Optimed's early development work. - CogniFit is likely to use the collaboration as another example of adoption within pharmaceutical, biotechnology, academic and CRO research settings. - Further study results or broader deployment were not disclosed.

The bottom line: - CogniFit and Eurofins Optimed are betting that digital cognitive testing can make early clinical research faster, more scalable and more data-rich.